BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 46 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,060 | -40.0% | 11,994 | 0.0% | 0.00% | – |
| Q1 2024 | $6,772 | +106.8% | 11,994 | 0.0% | 0.00% | – |
| Q4 2023 | $3,274 | +36.4% | 11,994 | 0.0% | 0.00% | – |
| Q3 2023 | $2,400 | -90.3% | 11,994 | 0.0% | 0.00% | – |
| Q2 2023 | $24,707 | -37.6% | 11,994 | 0.0% | 0.00% | – |
| Q1 2023 | $39,579 | +101.2% | 11,994 | 0.0% | 0.00% | – |
| Q4 2022 | $19,670 | -61.4% | 11,994 | +4.0% | 0.00% | – |
| Q3 2022 | $51,000 | +59.4% | 11,528 | 0.0% | 0.00% | – |
| Q2 2022 | $32,000 | -22.0% | 11,528 | -5.9% | 0.00% | – |
| Q1 2022 | $41,000 | -16.3% | 12,250 | 0.0% | 0.00% | – |
| Q4 2021 | $49,000 | -5.8% | 12,250 | -23.0% | 0.00% | – |
| Q3 2021 | $52,000 | -14.8% | 15,899 | 0.0% | 0.00% | – |
| Q2 2021 | $61,000 | -82.0% | 15,899 | -82.1% | 0.00% | – |
| Q1 2021 | $339,000 | -16.1% | 88,583 | -0.9% | 0.00% | – |
| Q4 2020 | $404,000 | -73.5% | 89,359 | -0.9% | 0.00% | – |
| Q3 2020 | $1,526,000 | +86.1% | 90,161 | +23.2% | 0.00% | – |
| Q2 2020 | $820,000 | +1201.6% | 73,182 | +442.9% | 0.00% | – |
| Q1 2020 | $63,000 | +16.7% | 13,479 | +6.1% | 0.00% | – |
| Q4 2019 | $54,000 | -3.6% | 12,705 | -12.1% | 0.00% | – |
| Q3 2019 | $56,000 | -1.8% | 14,462 | 0.0% | 0.00% | – |
| Q2 2019 | $57,000 | -9.5% | 14,462 | 0.0% | 0.00% | – |
| Q1 2019 | $63,000 | +18.9% | 14,462 | -2.8% | 0.00% | – |
| Q4 2018 | $53,000 | -7.0% | 14,872 | 0.0% | 0.00% | – |
| Q3 2018 | $57,000 | -1.7% | 14,872 | -0.0% | 0.00% | – |
| Q2 2018 | $58,000 | -1.7% | 14,873 | -20.6% | 0.00% | – |
| Q1 2018 | $59,000 | +1.7% | 18,727 | +25.9% | 0.00% | – |
| Q4 2017 | $58,000 | -4.9% | 14,873 | 0.0% | 0.00% | – |
| Q3 2017 | $61,000 | -1.6% | 14,873 | 0.0% | 0.00% | – |
| Q2 2017 | $62,000 | -1.6% | 14,873 | 0.0% | 0.00% | – |
| Q1 2017 | $63,000 | +61.5% | 14,873 | -3.2% | 0.00% | – |
| Q4 2016 | $39,000 | +2.6% | 15,366 | -2.4% | 0.00% | – |
| Q3 2016 | $38,000 | -13.6% | 15,741 | -13.6% | 0.00% | – |
| Q2 2016 | $44,000 | -10.2% | 18,228 | -0.9% | 0.00% | – |
| Q1 2016 | $49,000 | -5.8% | 18,401 | +0.9% | 0.00% | – |
| Q4 2015 | $52,000 | +23.8% | 18,228 | 0.0% | 0.00% | – |
| Q3 2015 | $42,000 | -36.4% | 18,228 | 0.0% | 0.00% | – |
| Q2 2015 | $66,000 | -15.4% | 18,228 | +4.2% | 0.00% | – |
| Q1 2015 | $78,000 | – | 17,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 400,000 | $1,068,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 493,191 | $1,317,000 | 0.07% |
| GUARDIAN CAPITAL ADVISORS LP | 10,000 | $23,000 | 0.00% |
| A.R.T. Advisors, LLC | 22,758 | $60,000 | 0.00% |
| Psagot Value Holdings Ltd. | 22,715 | $61,000 | 0.00% |
| TCI Wealth Advisors, Inc. | 1,100 | $3,000 | 0.00% |
| Penserra Capital Management LLC | 4,980 | $13,000 | 0.00% |
| D'Orazio & Associates, Inc. | 500 | $1,000 | 0.00% |
| CITIGROUP INC | 380 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,269 | $163,000 | 0.00% |